ID   EGV-4T
AC   CVCL_5500
SY   EGV4T; EGV 4T; EGV4-T; Enhanced Growth Variant-4 Tumorigenic
DR   JCRB; JCRB0229
DR   Wikidata; Q54832094
RX   PubMed=3319569;
RX   PubMed=3470760;
CC   Doubling time: ~37 hours (Note=Lot 03222005) (JCRB=JCRB0229).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
RX   PubMed=3319569; DOI=10.1289/ehp.877571; PMCID=PMC1474444;
RA   Nettesheim P., FitzGerald D.J.P., Kitamura H., Walker C.L., Gilmer T.M.,
RA   Barrett J.C., Gray T.E.;
RT   "In vitro analysis of multistage carcinogenesis.";
RL   Environ. Health Perspect. 75:71-79(1987).
//
RX   PubMed=3470760; DOI=10.1073/pnas.84.7.1804; PMCID=PMC304529;
RA   Walker C.L., Nettesheim P., Barrett J.C., Gilmer T.M.;
RT   "Expression of a fms-related oncogene in carcinogen-induced neoplastic
RT   epithelial cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:1804-1808(1987).
//